Compass Therapeutics, Inc. · NASDAQ:CMPX
Anderman Jonathan bought 25,000 Compass Therapeutics, Inc. shares (Form 4/A)
Traded Apr 29, 2026 · Filed Apr 30, 2026
On Apr 29, 2026, Anderman Jonathan (General Counsel) bought 25,000 Compass Therapeutics, Inc. shares at US$1.89 for US$47,250, leaving 196,000 shares. Filed Apr 30, 2026 (Form 4/A).
- Bought
- 25,000 shares
- Price
- US$1.89
- Value
- US$47,250
- Holding after
- 196,000 shares
- Trading plan
- No
- Role
- General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | Common Stock | Buy | 25,000 | US$1.89 | 196,000 | Direct |
Source
Related
- Compass Therapeutics, Inc.
- Anderman Jonathan
- Compass Therapeutics, Inc. shareholders
- Form 4 · Anderman Jonathan · Apr 29, 2026
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · May 15, 2026